Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in the Netherlands / NCT02113644
Recruiting Observational

Prevent CardioKids

NCT02113644 · tracked via the Priya Life Science Netherlands tracker
Sponsor
Maastricht University Medical Center
Phase
Observational
Started
2014-04
Last updated
2020-04-29

Condition(s) studied

Cardiovascular Disease

Investigational drug(s) / intervention(s)

Lifestyle intervention

Study summary

The aim of Prevent CardioKids is to evaluate to what extend disturbed vascular function markers are already present in children of different weight categories and whether these are age dependent. Also differences - and relationships - between vascular function measurements and plasma biomarkers between lean and overweight/obese children will be compared.

Eligibility

Sex
ALL
Min age
6 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participation in the COACH program * Aged between 6 and 18 years (at time of inclusion) * Overweight or obesity according to IOTF criteria In order to be eligible to participate in the control group, a subject must meet all of the following criteria: * Aged between 6 and 18 years * Normal weight according to the IOTF criteria * Undergo surgery for elective reasons Exclusion Criteria: * Retarded children * Children suffering from: * Inflammatory diseases: auto-immune diseases, inflammatory bowel diseases, hepatitis, dermatitis, nephritis, pancreatitis, gastro-enteritis, vasculitis, salpingitis, arthritis, osteomyelitis, myositis, ear-nose-throat infections * Allergic diseases: asthma, eczema, hay fever, food allergies * Oncologic diseases * Cystic fibrosis * Type 1 diabetes mellitus * Congenital metabolic diseases * Malnourished children

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Maastricht University Medical Center Maastricht Limburg Recruiting

More Maastricht University Medical Center trials in the Netherlands

Long-term Effects of Avocado Consumption on Health in Pre-diabetic Individuals Starting soon
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs Active, not recruiting
Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients Recruiting
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp Active, not recruiting
The Effectiveness of a Diet With Beef as Key Protein Component Versus a Plant-Based Diet to Support Integrated Muscle Protein Synthesis Rates in Healthy Older Individuals Recruiting

Other trials for the same condition

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial Recruiting
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels Active, not recruiting
Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques Recruiting
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02113644 on ClinicalTrials.gov ↗ ← All trials in the Netherlands